Exploring Analyst Estimates for Boston Scientific (BSX) Q2 Earnings, Beyond Revenue and EPS
Besides Wall Street's top-and-bottom-line estimates for Boston Scientific (BSX), review projections for some of its key metrics to gain a deeper understanding of how the company might have fared during the quarter ended June 2025.
Boston Scientific (BSX) Earnings Expected to Grow: What to Know Ahead of Next Week's Release
Boston Scientific (BSX) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Will Robust MedSurg Performance Fuel Boston Scientific's Q2 Earnings?
BSX eyes strong Q2 with MedSurg momentum, solid Cardiovascular growth and benefits from key tech acquisitions.
Why Boston Scientific (BSX) Outpaced the Stock Market Today
Boston Scientific (BSX) reached $104.33 at the closing of the latest trading day, reflecting a +1.09% change compared to its last close.
Boston Scientific (BSX) Crossed Above the 20-Day Moving Average: What That Means for Investors
Boston Scientific (BSX) is looking like an interesting pick from a technical perspective, as the company reached a key level of support. Recently, BSX crossed above the 20-day moving average, suggesting a short-term bullish trend.
3 AI-Driven Medical Device Stocks to Watch in 2025
BSX, JNJ and GEHC are leveraging AI to boost device performance, diagnostics and surgical precision in 2025.
Is Boston Scientific (BSX) a Buy as Wall Street Analysts Look Optimistic?
Investors often turn to recommendations made by Wall Street analysts before making a Buy, Sell, or Hold decision about a stock. While media reports about rating changes by these brokerage-firm employed (or sell-side) analysts often affect a stock's price, do they really matter?
These 2 Medical Stocks Could Beat Earnings: Why They Should Be on Your Radar
Investors looking for ways to find stocks that are set to beat quarterly earnings estimates should check out the Zacks Earnings ESP.
Is it Worth Adding Boston Scientific Stock to Your Portfolio Now?
BSX rides on strong MedSurg growth and strategic acquisitions amid currency headwinds.
Boston Scientific (BSX) Suffers a Larger Drop Than the General Market: Key Insights
In the most recent trading session, Boston Scientific (BSX) closed at $102.41, indicating a -1.37% shift from the previous trading day.
Will Boston Scientific (BSX) Beat Estimates Again in Its Next Earnings Report?
Boston Scientific (BSX) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
Boston Scientific Climbs 40.5% in a Year: What's Driving the Stock?
BSX rallies 40.5% in a year, fueled by WATCHMAN growth, MedSurg gains, acquisitions and global expansion efforts.
